Zhang H, Court N, Forman HJ
Here, we show that a branched aliphatic amino acid or methionine at position 585 of albumin is required for optimal receptor binding, which cannot be replaced to prevent enzymatic cleavage without negatively affecting FcRn engagement
Peptide therapy may be considered for individuals who: are recovering from surgery have sports-related injuries experience chronic joint discomfort want to support tissue healing are exploring regenerative treatment options want to support recovery without surgery A medical evaluation can help determine whether peptide therapy is appropriate
but participants in each meta-analysis must have the same condition
Fig.1 GLP-1 structure diagram GLP-1 drugs on market Current GLP-1 drugs available on market include benaglutide, exenatide, liraglutide, lixisenatide, PLGA-encapsulated long-acting exenatide, albiglutide, dulaglutide, Semaglutide, polyethylene glycol loxenatide injection, and oral semaglutide
AMP = adenosine monophosphate
